GL1X · GenesisL1 explorer

Research workbench

Crystal structures of glutaryl 7-aminocephalosporanic acid acylase: insight into autoproteolytic activation

Analyse Crystal structures of glutaryl 7-aminocephalosporanic acid acylase: insight… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
3S8R
Type
protein
Length
1,370 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Glutaryl-7-aminocephalosporanic-acid acylase
EC
3.5.1.93
UniProt
P07662
Pockets
13 · best druggability 0.67

Structure

x-ray diffraction · 2 distinct chains · 35% helix, 23% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AGlutaryl-7-aminocephalosporanic-acid acylase (EC 3.5.1.93)protein68435% helix, 23% strandP07662
BGlutaryl-7-aminocephalosporanic-acid acylase (EC 3.5.1.93)protein68635% helix, 23% strandP07662

Ligands and binding sites

  • GOL · Glycerol · additive · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

13 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
15800.670.7765empty
25430.660.7767empty
31850.520.7832empty
41410.490.7925empty
51370.460.7721GOL

Interfaces

1 interface between chains.

  • A–B · 445 Ų buried · 4 hydrogen bonds · protein-protein

Compared structures

  • 3S8R · Crystal Structures of Glutaryl 7-Aminocephalosporanic Acid Acylase: Insight into… · the same entry in another collection · chain A against A, TM-score 1.00
  • P07662 · AlphaFold monomer V2.0 prediction for glutaryl-7-aminocephalosporanic-acid acylase… · a predicted model of the same protein · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.